Tong Wu , Ting Wang , Hanlin Chen , Zhongyuan Tan , Yuanjiu Miao , Ning Chen , Zhenhua Zheng
{"title":"Ginsenoside Rb2 demonstrates potent antiviral activity against Zika virus infection","authors":"Tong Wu , Ting Wang , Hanlin Chen , Zhongyuan Tan , Yuanjiu Miao , Ning Chen , Zhenhua Zheng","doi":"10.1016/j.jgr.2025.03.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Zika virus (ZIKV) infection can result in severe neurological complications, yet no approved antiviral treatments are currently available. Ginseng, a medicinal herb extensively utilized in Asian traditional medicine, has demonstrated efficacy against various diseases, which has sparked interest in exploring its potential antiviral properties for the treatment of ZIKV.</div></div><div><h3>Methods</h3><div>We evaluated the antiviral effects of ginsenoside Rb2 (G-Rb2) in human neuronal cell lines (SK-N-SH and CCF-STTG) and in a lethal ZIKV-infected mouse model. The antiviral efficacy was assessed using bioluminescence imaging with a NanoLuc luciferase reporter ZIKV. <em>In vitro</em> assays were conducted to determine the direct impact of G-Rb2 on ZIKV, while surface plasmon resonance (SPR) was employed to analyze its interaction with ZIKV envelope proteins and viral particles.</div></div><div><h3>Results</h3><div>G-Rb2 (200 μM) significantly inhibited ZIKV infection <em>in vitro</em> and protected mice from ZIKV-induced mortality. Bioluminescence imaging validated its antiviral efficacy. <em>In vitro</em> studies demonstrated that incubation with G-Rb2 reduced viral infectivity, and SPR analysis confirmed direct binding between G-Rb2 and ZIKV components.</div></div><div><h3>Conclusion</h3><div>G-Rb2 effectively inhibits ZIKV infection both <em>in vitro</em> and <em>in vivo</em>, presumably through direct interaction with viral particles. Given the accessibility of ginseng and its established processing methods, G-Rb2 emerges as a promising candidate for the treatment of ZIKV in humans. Further research is warranted to elucidate its mechanisms of action and evaluate its clinical potential.</div></div>","PeriodicalId":16035,"journal":{"name":"Journal of Ginseng Research","volume":"49 4","pages":"Pages 406-414"},"PeriodicalIF":6.8000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ginseng Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1226845325000314","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Zika virus (ZIKV) infection can result in severe neurological complications, yet no approved antiviral treatments are currently available. Ginseng, a medicinal herb extensively utilized in Asian traditional medicine, has demonstrated efficacy against various diseases, which has sparked interest in exploring its potential antiviral properties for the treatment of ZIKV.
Methods
We evaluated the antiviral effects of ginsenoside Rb2 (G-Rb2) in human neuronal cell lines (SK-N-SH and CCF-STTG) and in a lethal ZIKV-infected mouse model. The antiviral efficacy was assessed using bioluminescence imaging with a NanoLuc luciferase reporter ZIKV. In vitro assays were conducted to determine the direct impact of G-Rb2 on ZIKV, while surface plasmon resonance (SPR) was employed to analyze its interaction with ZIKV envelope proteins and viral particles.
Results
G-Rb2 (200 μM) significantly inhibited ZIKV infection in vitro and protected mice from ZIKV-induced mortality. Bioluminescence imaging validated its antiviral efficacy. In vitro studies demonstrated that incubation with G-Rb2 reduced viral infectivity, and SPR analysis confirmed direct binding between G-Rb2 and ZIKV components.
Conclusion
G-Rb2 effectively inhibits ZIKV infection both in vitro and in vivo, presumably through direct interaction with viral particles. Given the accessibility of ginseng and its established processing methods, G-Rb2 emerges as a promising candidate for the treatment of ZIKV in humans. Further research is warranted to elucidate its mechanisms of action and evaluate its clinical potential.
期刊介绍:
Journal of Ginseng Research (JGR) is an official, open access journal of the Korean Society of Ginseng and is the only international journal publishing scholarly reports on ginseng research in the world. The journal is a bimonthly peer-reviewed publication featuring high-quality studies related to basic, pre-clinical, and clinical researches on ginseng to reflect recent progresses in ginseng research.
JGR publishes papers, either experimental or theoretical, that advance our understanding of ginseng science, including plant sciences, biology, chemistry, pharmacology, toxicology, pharmacokinetics, veterinary medicine, biochemistry, manufacture, and clinical study of ginseng since 1976. It also includes the new paradigm of integrative research, covering alternative medicinal approaches. Article types considered for publication include review articles, original research articles, and brief reports.
JGR helps researchers to understand mechanisms for traditional efficacy of ginseng and to put their clinical evidence together. It provides balanced information on basic science and clinical applications to researchers, manufacturers, practitioners, teachers, scholars, and medical doctors.